THE BIOLOGIC SIGNIFICANCE OF CYTOLOGIC ATYPIA IN PROGESTOGEN-TREATED ENDOMETRIAL HYPERPLASIA

被引：175

作者：

FERENCZY, A ^{[1
]}

GELFAND, M ^{[1
]}

机构：

[1] SIR MORTIMER B DAVIS JEWISH GEN HOSP,DEPT OBSTET & GYNECOL,MONTREAL H3T 1E2,QUEBEC,CANADA

来源：

关键词：

D O I：

10.1016/0002-9378(89)90103-8

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：126 / 131

页数：6

共 28 条

[21]

MCBRIDE JM, 1959, J OBSTET GYNAECOL, V66, P288

[22]

PAGE DL, 1985, CANCER, V55, P2698, DOI 10.1002/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO

[23]

2-A

[24] PRECURSORS OF ENDOMETRIAL CARCINOMA [J].

SHERMAN, AI ;

BROWN, S .

TAVASSOLI, F ;

KRAUS, FT .

[26] PRECANCEROUS LESIONS OF ENDOMETRIUM [J].

WELCH, WR ;

SCULLY, RE .

[27] TREATMENT OF PERSISTENT ENDOMETRIAL HYPERPLASIA WITH PROGESTINS [J].

WENTZ, WB .

WENTZ, WB .